A U.S. partner building an assessed facility base.
Pacific Biolúme is developing the RCX Standard and, as stated intent, a supply relationship with the facilities that meet it. We are making connections with international regenerative aesthetic sources and device makers, and our focus is bringing the emerging technologies from Japan to the U.S.
What a certified facility base would change.
Distribution without assessment is a transaction: product in, invoice out, no shared standard between the laboratory that made it and the clinic that uses it.
A network assessed against a documented standard is a different proposition. It gives a manufacturer a defined channel with defined expectations — where the documentation you provide is actually read, and where the facility on the other end has been asked to demonstrate something.
No such network exists yet. It is the second stage of what is being built, after the Standard.

Direct relationships with the manufacturers themselves.
Our stated intent is to source through direct relationships with international manufacturers, with no layers of intermediaries between the laboratory that makes a product and the company that intends to place it.
That is a higher bar to clear than buying through a broker, and it is deliberate. The documentation that matters to a facility is the documentation only the manufacturer can provide.
Five things, in every conversation.
- 01
Donor traceability and sourcing documentation
Where the material comes from, how the donor was screened, and the records that travel with it.
- 02
Manufacturing standards
The process, the facility, and the controls behind both.
- 03
Regulatory posture
Where the product stands in its home jurisdiction, and what that means for the United States.
- 04
Clinical data
What has been studied, in what setting, and what remains unproven.
- 05
Supply reliability
Whether the product can arrive consistently, at the specification it claims.
Not a market-entry consultancy.
We do not provide regulatory strategy, market-entry planning or registration services. Manufacturers seeking U.S. entry strategy are referred to JCA Global Regenerative Advisory.
JCA Global Regenerative AdvisoryTell us what you make.
Submit a short inquiry and attach the document that best explains your product — a certificate of analysis, a technical dossier, or a summary of your manufacturing controls.
